WuXi ATU will manufacture and test WU-NK-101, a groundbreaking cell therapy for cancer patients. The global clinical trials market is projected to reach $93.42 billion by 2032, driven by rising pharmaceutical R&D investments and an increasing number of trials, particularly in Phase III and autoimmune indications. Major players include IQVIA, LabCorp, and WuXi AppTec, focusing on innovative therapies and AI integration to enhance drug discovery efficiency.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
